跳至主要内容
临床试验/NCT00764959
NCT00764959终止不适用

Post-Market Study of the Linear™ Hip System

Encore Medical, L.P.1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2007年10月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
200
试验地点
1
主要终点
The use and efficacy of the Encore Linear™ Hip System

研究概览

简要总结

The purpose of this study is to evaluate the use and efficacy of the Encore Linear™ Hip System in a group of 200 patients for whom data has already been collected.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Have hip joint disease related to one or more of the following
  • osteoarthritis
  • rheumatoid arthritis
  • femoral fracture
  • correction of a functional deformity
  • avascular necrosis of the natural femoral head
  • Skeletal maturity
  • Patient is likely to be available for evaluation for the duration of the study
  • Able and willing to sign the informed consent and follow study procedures
  • Patient is not pregnant
  • No infection present
  • No known materials sensitivity
  • Patient is over 18 years of age

排除标准

  • Skeletal immaturity
  • Infection or sepsis
  • Insufficient bone quality that may affect the stability of the implant
  • Muscular, neurologic or vascular deficiencies which compromise the affected extremity
  • Alcoholism or other addictions
  • Prisoners
  • High levels of physical activity
  • Patient is pregnant
  • Loss of ligamentous structures
  • Materials sensitivity
  • Patient is under 18 years of age

结局指标

主要结局

The use and efficacy of the Encore Linear™ Hip System

时间窗: 2 year

次要结局

未报告次要终点

研究者

申办方类型
Industry

研究点 (1)

Loading locations...

相似试验